经口机器人手术与上气道刺激术在特定阻塞性睡眠呼吸暂停患者中的比较
本研究回顾性比较了2011至2016年间由同一术者实施的经口机器人手术(TORS)与上气道刺激术(UAS)治疗阻塞性睡眠呼吸暂停(OSA)的效果。纳入BMI<35且AHI在20-65之间的患者,TORS组经药物诱导睡眠内镜重新评估符合UAS标准。结果显示UAS组平均AHI降低33.3,TORS组降低12.7;治愈率(AHI<5)分别为70.3%和10.0%。结论认为符合两种手术标准的患者接受UAS的客观指标改善更显著。
要点
- UAS组平均AHI降低33.3,TORS组降低12.7。
- UAS组治愈率(AHI<5)为70.3%,TORS组为10.0%。
- 研究提示符合两种手术标准的OSA患者可能从UAS获得更大获益。
核心结论
- 在同时符合TORS和UAS标准的OSA患者中,接受UAS治疗的患者在多项客观指标上改善更显著。
研究设计与样本
- 回顾性病历审查,比较2011至2016年由单一术者实施的TORS与UAS治疗OSA的结果。
- 纳入标准为BMI<35且AHI在20-65之间,符合UAS植入标准。
- TORS组患者术前药物诱导睡眠内镜记录被重新评估,筛选出符合UAS标准的前后向软腭后塌陷患者与UAS组比较。
主要发现
- TORS组平均AHI降低12.7,UAS组平均AHI降低33.3。
- 总体治愈率(定义为AHI<5)TORS组为10.0%,UAS组为70.3%。
关键数值与推荐
- 纳入标准:BMI<35且AHI在20-65之间。
- 治愈定义为AHI<5。
- 证据等级:4。
临床怎么用
- 对于同时符合TORS和UAS手术标准的OSA患者,UAS可能带来更优的客观指标改善。
- 研究结果可能有助于指导未来OSA手术治疗算法的制定。
局限性
- 本研究为回顾性病历审查,证据等级为4。
- 样本来自单一术者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Transoral robotic surgery (TORS) has been used to treat obstructive sleep apnea (OSA) since 2009, with recent meta-analysis showing an average reduction of apnea-hypopnea index (AHI) from 44.3 to 17.0. In 2014, upper airway stimulation surgery (UAS) was approved for OSA treatment, with results showing an average AHI reduction from 32.0 to 15.3. Given there was a period when TORS was available and UAS was not, we looked at a subset of patients treated with TORS but who could have qualified for UAS and compared their outcomes to patients who received UAS. METHODS: This is a retrospective chart review comparing TORS to UAS in treatment of OSA performed by a single surgeon between 2011 and 2016. Inclusion criteria were a body mass index less than 35 and AHI between 20 and 65 consistent with criteria for UAS implantation. Patients who received TORS and met the inclusion criteria had their preoperative drug-induced sleep endoscopy recordings re-evaluated. Patients with anteroposterior retropalatal collapse that would have qualified them for UAS had their outcomes compared to patients who received UAS. RESULTS: Results between TORS and UAS showed an average AHI reduction of 12.7 and 33.3, respectively. Overall cure rate, defined as AHI < 5, was 10.0% and 70.3%, respectively. CONCLUSION: Results of this study indicate that, when met with criteria for both TORS and UAS, patients receiving UAS had greater improvement in several objective measures of OSA. Studies like this may help direct future treatment algorithms for surgical management of OSA. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:256-258, 2019.
引用
- Yu JL, Mahmoud A, Thaler ER, et al. Transoral robotic surgery versus upper airway stimulation in select obstructive sleep apnea patients. Laryngoscope. 2018. PMID: 30208225. doi:10.1002/lary.27487
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。